| 发明名称 |
Predictive biomarker of survival in the treatment of renal cell carcinoma |
| 摘要 |
Methods and compositions are disclosed for predicting and treating the clinical benefit to a human renal cell carcinoma patient prior to their treatment with a VEGFR inhibitor and an Ang2 inhibitor. |
| 申请公布号 |
AU2012275346(B2) |
申请公布日期 |
2016.03.17 |
| 申请号 |
AU20120275346 |
申请日期 |
2012.06.28 |
| 申请人 |
AMGEN INC. |
发明人 |
ANDERSON, ABRAHAM ANTONIO;WEINREICH, DAVID M. |
| 分类号 |
A61K38/00;A61K31/17;A61K31/435;A61K39/00;G01N33/50;G01N33/574 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
